TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA

Dintsios CM, Hagen A, Gerhardus A, Krauth C (2008) .

Conference Abstract | Published | English

No fulltext has been uploaded

Author
; ; ;
Publishing Year
ISSN
PUB-ID

Cite this

Dintsios CM, Hagen A, Gerhardus A, Krauth C. TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA.
Dintsios, C. M., Hagen, A., Gerhardus, A., & Krauth, C. (2008). TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. Presented at the .
Dintsios, C. M., Hagen, A., Gerhardus, A., and Krauth, C. (2008).“TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”.
Dintsios, C.M., et al., 2008. TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA.
C.M. Dintsios, et al., “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”, BLACKWELL PUBLISHING, 2008.
Dintsios, C.M., Hagen, A., Gerhardus, A., Krauth, C.: TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA. (2008).
Dintsios, C. M., Hagen, A., Gerhardus, Ansgar, and Krauth, C. “TISSUE ENGINEERING OF VALVED VENOUS CONDUITS (VVC) VERSUS CONSERVATIVE THERAPY IN PATIENTS WITH CHRONIC VENOUS INSUFFICIENCY (CVI). A DECISION ANALYTIC MODEL USING EXPERT ESTIMATED UTILITIES BASED ON DERIVED DATA FROM ANIMAL STUDIES AS A PRE-MARKETING TECHNOLOGY ASSESSMENT APPROACH WITH GERMAN DATA”., BLACKWELL PUBLISHING, 2008.
This data publication is cited in the following publications:
This publication cites the following data publications:

Export

0 Marked Publications

Open Data PUB

Web of Science

View record in Web of Science®

Search this title in

Google Scholar